feed,title,long_url,short_url
SeekingAlpha,Aritzia announces normal course issuer bid,https://seekingalpha.com/news/3925404,
SeekingAlpha,Horizon says auto-immune disease candidate met another main goal in phase 2 trial,https://seekingalpha.com/news/3925403,
